The goal of the grant process is a serious peer review of all proposals. Investigators are encouraged to keep their proposals short and the process is not onerous.
Considerable latitude is given to the investigators in terms of the work proposed.
Both the Board of Directors and the Medical Advisory Board concur that some of the most important advances in understanding the disease will most likely occur by enabling brilliant minds to pursue some of their most creative theories. As most grants are determined in June, the Medical Advisory Board reviews all new proposals and those from grantees requesting renewal in late spring. The Medical Advisory Board members meet in person or via telephone conference at least twice a year and more often as required. Grants are awarded in two installments for a period covering October 1 September 30. Receipt of the second installment of the year s grant is contingent upon review of the submitted reports and a recommendation from the Medical Advisory Board.